| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $504,173,971 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG071024 | Short and long-term consequences of wildfires for Alzheimer's disease and related dementias | 000 | 4 | NIH | 3/11/2025 | $552,587 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HD118713 | Advancing pharmacy-based delivery of primary STI and HIV prevention for cisgender women | 000 | 1 | NIH | 9/5/2025 | $793,462 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HD118713 | Advancing pharmacy-based delivery of primary STI and HIV prevention for cisgender women | 001 | 1 | NIH | 9/8/2025 | $191,846 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K01AA032461 | Centering HIV Stigma in Clinical Conversations to increase Alcohol Treatment Uptake (CHAT) | 000 | 1 | NIH | 8/29/2025 | $179,959 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | RF1AG078169 | Hybrid efficacy-effectiveness trial to promote goals-of-care discussions for patients with Alzheimer's disease and related dementias and their family caregivers | 000 | 4 | NIH | 9/10/2025 | $2,753,401 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UH3HL165064 | A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity | 000 | 4 | NIH | 9/3/2025 | $2,849,004 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08DK141910 | Intestinal chondroitin sulfate glycosaminoglycans and their role in inflammatory bowel disease | 000 | 1 | NIH | 9/4/2025 | $164,188 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00LM014579 | Collaboratively Describing Community-Informed Social Drivers of Health for Patients Living with HIV: From Patient Perspectives to the Electronic Health Record | 000 | 3 | NIH | 9/10/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21AI185169 | Development of novel agents to eliminate TB persisters | 000 | 1 | NIH | 8/20/2025 | $301,826 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08AI177767 | Interferon gamma-dependent immunity to Mycobacterium tuberculosis mediated by regulation of inflammation by lung macrophages | 000 | 1 | NIH | 9/1/2025 | $188,760 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R25DK137747 | Mentored Urology Research Experience | 000 | 1 | NIH | 8/29/2025 | $106,395 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21MH139056 | Development of genetically encoded sex hormone biosensors to understand neuroactive steroid signaling dynamics in vivo | 000 | 1 | NIH | 8/31/2025 | $461,714 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R00AA030591 | Exploring affect-motivated alcohol use as a value-based decision-making process | 000 | 3 | NIH | 8/29/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R21DK144657 | Submicron-Resolution Integrated Spatial Transcriptomics and Proteomics for Studying Kidney Disease | 000 | 1 | NIH | 8/29/2025 | $404,883 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08HL178490 | The dynamic role of the alveolar macrophage during pulmonary bacterial infection | 000 | 1 | NIH | 8/20/2025 | $161,890 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM159916 | Precise GI Drug Delivery and Modeling with Pharmacomicrobiomics | 000 | 1 | NIH | 8/19/2025 | $427,625 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R33NS130134 | Evaluating the disease modifying properties of dimethyl fumarate (DMF) for the prevention and treatment of pharmacoresistant epilepsy | 000 | 2 | NIH | 8/13/2025 | $383,265 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG057381 | Physical resilience is a predictor of healthy aging | 002 | 8 | NIH | 6/10/2025 | $52,731 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K08AG090629 | Neuromuscular changes in the aging larynx | 000 | 1 | NIH | 8/13/2025 | $161,892 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31AI191409 | Landscape Immunity, Climate, and Yellow Fever Risk | 000 | 1 | NIH | 8/14/2025 | $47,459 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31AI191409 | Landscape Immunity, Climate, and Yellow Fever Risk | 001 | 1 | NIH | 8/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG057381 | Physical resilience is a predictor of healthy aging | 001 | 8 | NIH | 3/18/2025 | $593,233 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AR077560 | Dynamic OCE with acoustic micro-tapping for in vivo monitoring of skin graft surgeries | 001 | 5 | NIH | 4/29/2025 | $46,729 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AR077560 | Dynamic OCE with acoustic micro-tapping for in vivo monitoring of skin graft surgeries | 000 | 5 | NIH | 3/13/2025 | $600,840 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K23HL168162 | Improving prediction of persistent hypoxemic respiratory failure to support clinical trial enrichment | 000 | 1 | NIH | 8/13/2025 | $186,408 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R03ES037047 | Wildfire-specific particulate matter exposure during pregnancy and early life airway outcomes | 000 | 1 | NIH | 8/14/2025 | $155,500 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI183979 | Expanding access and impact of tuberculosis preventive therapy: Community-friendly delivery and monitoring of TPT to improve uptake and reduce TB transmission | 000 | 1 | NIH | 8/19/2025 | $690,538 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T42OH008433 | OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42) | 01 | 20 | CDC | 7/16/2025 | $1,800,000 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01EB034222 | Integrated PET+DBT for optimization of breast cancer therapy | 000 | 2 | NIH | 5/15/2025 | $633,934 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31DA059262 | Exploration of the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders | 003 | 2 | NIH | 8/11/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31DA059262 | Exploration of the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders | 000 | 2 | NIH | 1/27/2025 | $45,255 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HL155035 | A K63-Ubiquitination Dependent Necroptosis Signaling Network in the Heart | 000 | 5 | NIH | 1/28/2025 | $388,750 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA257563 | An integrated polymeric carrier for subunit cancer vaccines | 001 | 5 | NIH | 5/22/2025 | $51,753 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA257563 | An integrated polymeric carrier for subunit cancer vaccines | 000 | 5 | NIH | 2/12/2025 | $465,792 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI181634 | Identifying critical determinants of vaccine-induced cellular and humoral immunity from birth through childhood in HIV-exposed and unexposed children | 000 | 2 | NIH | 2/13/2025 | $577,777 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 006 | 6 | NIH | 7/1/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 006 | 6 | NIH | 7/1/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI155416 | Regulation of RNA sensing and viral restriction by RNA structures | 000 | 3 | NIH | 2/25/2025 | $428,013 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | RF1MH132148 | Scaling Low-Barrier Care to Engage People with Complex Needs in HIV Treatment | 000 | 4 | NIH | 8/18/2025 | $1,381,715 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R33DC021643 | mHealth OAE: Towards Universal Newborn Hearing Screening in Kenya (mTUNE) | 000 | 3 | NIH | 8/20/2025 | $324,627 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | RF1MH129234 | Simplifying PrEP delivery: One-stop service pathway to improve PrEP care efficiency and continuation in Kenya | 000 | 4 | NIH | 8/15/2025 | $1,220,378 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DC022585 | Auditory predictors of late language emergence | 000 | 1 | NIH | 5/27/2025 | $2,361,470 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R33NS126626 | Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures | 000 | 3 | NIH | 8/18/2025 | $373,489 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DA054317 | Transcriptional, functional, and circuit profiling at single cell resolution of neuronal ensembles engaged by heroin relapse | 001 | 5 | NIH | 4/11/2025 | $43,226 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DA054317 | Transcriptional, functional, and circuit profiling at single cell resolution of neuronal ensembles engaged by heroin relapse | 000 | 5 | NIH | 3/20/2025 | $389,045 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DA061769 | Development of computational and AI/ML tools to accelerate discovery of vaccines and antibodies against nitazenes and fentanyl analogs | 000 | 1 | NIH | 8/21/2025 | $637,128 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM159828 | Capillaric microfluidics for integrated, self-powered, and self-regulated sample preparation in miniaturized mass spectrometry systems | 000 | 1 | NIH | 8/19/2025 | $427,625 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T32GM159560 | Drug Action, Metabolism and Kinetics Training Grant | 000 | 1 | NIH | 8/19/2025 | $352,624 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R03HD119321 | Assessment of Implementation Strategies for an Innovative Facility-Specific Human Milk Pasteurizer in an Ethiopian NICU | 001 | 1 | NIH | 9/12/2025 | $30,077 |
|
